Diplomat Pharmacy celebrates its initial public offering and first day of trading on the New York Stock Exchange under the ticker 'DPLO.' Diplomat chairman and chief executive Phil Hagerman details how the company's focus on specialization helped the company transition itself from a neighborhood pharmacy to the largest independent specialty pharmacy in the U.S. Hagerman weighs in on the company's business strategy, which is patient-focused and factored into the company's decision not to sell cigarettes or other tobacco products nearly 20 years before CVS-Caremark pulled tobacco products from its shelves. Hagerman also talks the pricing of Diplomat's shares, which came in below the initial range, and how the company aims to grow in the future.

If you liked this article you might like

Masco, Diplomat Pharmacy, Vail Resorts: 'Mad Money' Lightning Round

Masco, Diplomat Pharmacy, Vail Resorts: 'Mad Money' Lightning Round

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

Amazon's Possible Move Into Pharmacies Has Everyone in Health Industry Talking

Amazon's Possible Move Into Pharmacies Has Everyone in Health Industry Talking

5 Earnings Short-Squeeze Plays: Snap, NVIDIA & More

5 Earnings Short-Squeeze Plays: Snap, NVIDIA & More

5 Earnings Short-Squeeze Plays to Boost Your Returns

5 Earnings Short-Squeeze Plays to Boost Your Returns